The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metformin (met) use and outcome of sunitinib (Su) treatment (tx) in diabetic patients (pts) with metastatic renal cell carcinoma (mRCC).
 
Daniel Keizman
No Relationships to Disclose
 
Maya Ish-Shalom
No Relationships to Disclose
 
Avivit Peer
No Relationships to Disclose
 
Adi Chish
No Relationships to Disclose
 
Avishay Sella
No Relationships to Disclose
 
Maya Gottfried
No Relationships to Disclose
 
Hans J. Hammers
No Relationships to Disclose
 
Mario A. Eisenberger
Honoraria - Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ipsen
Research Funding - Genentech; Sanofi; Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Astellas Pharma; Bayer
 
Victoria J. Sinibaldi
No Relationships to Disclose
 
Victoria Neiman
No Relationships to Disclose
 
Eli Rosenbaum
No Relationships to Disclose
 
David Sarid
No Relationships to Disclose
 
Eliahu Gez
No Relationships to Disclose
 
Wilmosh Mermershtain
No Relationships to Disclose
 
Keren Rouvinov
No Relationships to Disclose
 
Rony Weitzen
No Relationships to Disclose
 
Rony Weitzen
No Relationships to Disclose
 
Raanan Berger
No Relationships to Disclose
 
Michael Anthony Carducci
Honoraria - Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Medivation
Research Funding - Amgen (Inst)